Cargando…
Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial
BACKGROUND: Dexamethasone 6 mg daily for 10 days is the recommended treatment for patients with severe or critical coronavirus disease 2019 (COVID-19). The evidence on the benefit of high-dose dexamethasone is limited. The goal of this study was to assess the effects of 6 mg daily vs. 20 mg daily of...
Autores principales: | Wu, Huimin, Daouk, Salim, Kebbe, Jad, Chaudry, Fawad, Harper, Jarrod, Brown, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529091/ https://www.ncbi.nlm.nih.gov/pubmed/36190994 http://dx.doi.org/10.1371/journal.pone.0275217 |
Ejemplares similares
-
Comparison of Efficacy and Safety of Low-Dose Versus High-Dose Dexamethasone in Hospitalized COVID-19 Patients: A Meta-Analysis
por: Waheed, Muhammad Daniyal, et al.
Publicado: (2023) -
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021) -
Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023) -
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
por: Pinzón, Miguel Alejandro, et al.
Publicado: (2021) -
Corynebacterium macginleyi: A cause of ventilator associated pneumonia in an immunocompromised patient
por: Kebbe, Jad, et al.
Publicado: (2015)